Children's Hospital Boston Researchers ID Protein That May Explain Paclitaxel Resistance

The researchers used a proteomics approach to discover that overexpression of prohibitin1 on the cell surface corresponded to resistance to the drug, one of the most successful cancer therapies in history.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.